Results from trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life

A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest top-line results from the phase 2 LiBBY (Life’s End Benefits of cannaBidiol and tetrahYdrocannabinol) clinical trial. The findings were reported for the first time at the Alzheimer’s Association International Conference 2026 in London and online.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup